Robuta

Our strategy is to create a sustainable, diversified portfolio of 15-20 globally leading healthcare businesses companies over a rolling 10-year period.

Autolus is a clinical-stage biopharmaceutical company focusing on the development of precisely targeted, controlled and highly active T effector cell therapies.

iOnctura is a clinical-stage oncology company developing innovative therapies for neglected and hard-to-treat cancers.

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high...